|
Locus | Gene | Chromosomal localization | Type of inheritance | Protein | Function | Reference |
|
DFNA1 | DIAPH1 | 5q31 | AD | Diaphanous 1 | Actin polymerisation (cytoskeleton) | [44] |
DFNA2A | KCNQ4 | 1p34 | AD | KCNQ4 | Voltage-gated K+ channel (ion haemostasis) | [51] |
DFNA2B | GJB3 (Cx31) | 1p34 | AD | Connexin 31 | Gap junction (ion haemostasis) | [57] |
DFNA3A | GJB2 (Cx26) | 13q12 | AD | Connexin 26 | Gap junction (ion haemostasis) | [54] |
DFNA3B | GJB6 (Cx30) | 13q12 | AD | Connexin 30 | Gap junction (ion haemostasis) | [55] |
DFNA4 | MYH14 | 19q13 | AD | Nonmuscle myosin heavy chain XIV | Transport | [31] |
DFNA4 | CAECAM16 | 19q13 | AD | Carcinogenic antigen-related cell adhesion molecule 16 | TM attachment crown (adhesion) | [11] |
DFNA8/12 | TECTA | 11q22-24 | AD | A-tectorin | Stability and structure of TM (ECM) | [28] |
DFNA9 | COCH | 14q12-q13 | AD | Cochlin | Structure of spiral limbus | [30] |
DFNA10 | EYA4 | 6q22-q23 | AD | Eyes absent 4 | Regulation of transcription (transcription factor) | [42] |
DFNA11 | MYO7A | 11q12.3-q21 | AD | Myosin VIIa | Transport | [43] |
DFNA13 | COLL11A2 | 6p21 | AD | Type XI collagen α2 | Stability and structure of TM (ECM) | [26] |
DFNA15 | POU3F4 | 5q31 | AD | Class 3 POU | Regulation of transcription (transcription factor) | [33] |
DFNA17 | MYH9 | 22q | AD | Nonmuscle myosin heavy chain IX | Transport | [24] |
DFNA20/26 | ACTG1 | 17q25 | AD | γ-actin | Building cytoskeleton (cytoskeleton) | [50, 56] |
DFNA22 | MYO6 | 6q13 | AD | Myosin VI | Regulation of exocytosis, anchoring stereocilia (cytoskeleton) | [29] |
DFNA25 | SLC17A8 | 12q21-24 | AD | VGLUT-3 | Regulation of exocytosis and endocytosis of glutamate (transport) | [32] |
DFNA28 | TFCP2L3 | 8q22 | AD | Transcription factor CP2-like 3 | Regulation of transcription (transcription factor) | [52] |
DFNA48 | MYO1A | 12q13-q14 | AD | Myosin Ia | Transport | [34] |
DFNA50 | MIR96 | 7q32 | AD | MicroRNA96 | Regulation of transcription (transcription factor) | [12] |
DFNA51 | TJP2 | | AD | Tight junction protein 2 | Cell cycle signaling, binding tight junctions to membrane | [13] |
DFNA56 | TNC | 9q31.3-q34.3 | AD | Tenascin-C | Stability and structure of TM (ECM) | [14] |
DFNA64 | SMAC/DIABLO | 12q24.31-12q24.32 | AD | Second Mitochondria-Derived Activator of Caspase/Direct Inhibitor of Apoptosis protein Binding protein with a low pI | Cell cycle signaling | [15] |
DFNA65 | TBC1D24 | 16p13.3 | AD | Tbc1 domain family, member 24 | Encoding a GTPase-activating protein expressed in the cochlea | [16, 17] |
DFNA67 | OSBPL2 | 20q13.2-q13.33 | AD | Oxysterol-binding Protein-like Protein 2 | Intracellular transport of lipids, particularly oxysterol (transport) | [40, 45] |
HOMER2 | 15q25.2 | AD | Homer, drosophila, homolog of 2 | Negative regulator of T cell activation | [46] |
DFNB1A | GJB2 (Cx26) | 13q11-q12 | AR | Connexin 26 | Gap junction (ion haemostasis) | [13] |
DFNB1B | GJB6 (Cx30) | 13q12 | AR | Connexin 30 | Gap junction (ion haemostasis) | [49] |
DFNB2 | MYO7A | 11q | AR | Myosin VIIa | Transport | [25, 43] |
DFNB3 | MYO15A | 17p11.2 | AR | Myosin Xva | Transport | [18] |
DFNB4 | SLC26A4 | 7q31 | AR | Pendrin | Acid-base balance of endolymph (ion haemostasis) | [39] |
DFNB9 | OTOF | 2p23-p22 | AR | Otoferlin | Fusion of synaptic vesicles with Ca+2 (transport) | [38] |
DFNB12 | CDH23 | 10q21-q22 | AR | Cadherin 23 | Lateral and tip link (adhesion) | [19] |
Modifier of DNFB12 | ATP2b2/PMCA2 | 1p32.3 | AR | ATP2b2 | ATP dependent Ca+2 pump | [53] |
DFNB16 | STRC | 15q15 | AR | Stereocilin | TM attachment links (adhesion) | [20] |
DFNB18 | USH1C | 11p15.1 | AR | Harmonin | Scaffolding protein (adhesion) | [48, 58] |
DFNB21 | TECTA | 11q22-q24 | AR | α-tectorin | Stability and structure of TM (ECM) | [10] |
DFNB22 | OTOA | 16p12.2 | AR | Otoancorin | TM attachment to nonsensroy cells (adhesion) | [21] |
DFNB23 | PCDH15 | 10q21-q22 | AR | Protocadherin 15 | Lateral and tip link (adhesion) | [22] |
DFNB24 | RDX | 11q23 | AR | Radixin | Actin binding to plasma membrane (cytoskeleton) | [23] |
DFNB28 | TRIOBP | 22q13.1 | AR | Trio-binding protein | Actin binding and organisation (cytoskeleton) | [27, 35] |
DFNB29 | CLDN14 | 21q22.3 | AR | Claudin 14 | Tight junction (ion haemostasis) | [36] |
DFNB30 | MYO3A | 10p11.1 | AR | Myosin IIIa | Transport | [37] |
DFNB31 | WHRN | 9q32-q34 | AR | Whirlin | Scaffolding protein (adhesion) | [41] |
DFNB35 | ESRRB | 14q21.1-q24.3 | AR | Oestrogen-related receptor β | Regulation of transcription (transcription factor) | [47] |
DFNB36 | ESPN | 1p36.3-p36.1 | AR | Espin | Actin crosslinking and bundling (cytoskeleton) | [59] |
DFNB37 | MYO6 | 6q13 | AR | Myosin VI | Regulation of exocytosis, stereocilia anchoring (transport) | [60] |
DFNB49 | TRIC | 5q12.3-q14.1 | AR | Tricellulin | Tight junction (ion haemostasis) | [53] |
DFNB53 | COL11A2 | 6p21.3 | AR | Type XI collagen α2 | Stability and structure of TM (ECM) | [61] |
DFNB61 | SLC26A5 | | AR | Prestin | Electromotility | [62] |
DFNB67 | TMHS | 6p21.3 | AR | Tetraspan membrane protein | Transient link (adhesion) | [63] |
DFNB73 | BSND | | AR | Barttin | K+ channel maturation and trafficking (ion haemostasis) | [64] |
DFNB79 | TPRN | 9q34.3 | AR | Taperin | Actin regulation (cytoskeleton) | [65] |
DFNB84 | PTPRQ | 12q21.31-q21.2 | AR | Protein tyrosine phosphate receptor Q | Transient link (adhesion) | [66] |
DFNB91 | GJB3 | 6p25 | AR | Connexin 31 | Gap junction (ion haemostasis) | [67] |
DFNB93 | CABP2 | 11q13.2 | AR | Calcium-binding protein 2 | (ion haemostasis) | [68] |
DFNB94 | NARS2 | 11q14.1 | AR | Asparaginyl-tRNA synthetase 2 | (transport) | [69] |
DFNB97 | MET | 7q31.2 | AR | MET protooncogene | Cell-surface receptor for hepatocyte growth factor (adhesion) | [70] |
DFNB98 | TSPEAR | 21q22.3 | AR | Thrombospondin-type laminin g domain and ear repeats | Cell permeabilization (transport) | [71] |
DFNB99 | TMEM132E | 17q12 | AR | Transmembrane protein 132e | Extracellular receptor | [72] |
DFNB101 | GRXCR2 | 5q32 | AR | Glutaredoxin, cysteine-rich 2 | Organisation of stereocilia (adhesion) | [73] |
DFNB102 | EPS8 | 12p12.3 | AR | Epidermal growth factor receptor pathway substrate 8 | Regulating Rac-specific GEF activity (transcription factor) | [74] |
DFNB103 | CLIC5 | 6p21.1 | AR | Chloride intracellular channel 5 | (ion haemostasis) | [75] |
FAM65B | 6p22.3 | AR | Family with sequence similarity 65, member b | (Cytoskleton) | [76] |
Usher syndrome | SANS/USH1G | 17q24-25 | AR | SANS | Scaffolding protein (adhesion) | [77] |
Usher syndrome | USH2A | 1q41 | AR | Usherin | Ankle link (adhesion) | [78] |
Usher syndrome | VLGR1B | | AR | Very large G protein-coupled receptor 1 | Ankle link (adhesion) | [79] |
DFN2 | PRPS1 | Xq22.3 | X-linked | Phosphoribosylpyrophosphate synthetase 1 | Purine and pyrimidine biosynthesis | [80] |
DFN3 | POU3F4 | Xq21 | X-linked | Class 3 POU | Regulation of transcription (transcription factor) | [81] |
DFN6 | SMPX | Xp21.2 | X-linked | Small muscle protein X-linked | Stereocilial development and maintenance (cytoskeleton) | [82] |
DFNX6 | COL4A6 | Xq22.3 | X-linked | Collagen, type IV, alpha-6 | Stability and structure of TM (ECM) | [83] |
|